SUBSCRIBE
SUBSCRIBE
News   Business

Seattle Genetics, Inc. Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results

October 23, 2009 | 
1 min read
BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the third quarter and nine months ended September 30, 2009. The company also highlighted recent product development progress.
Earnings
MORE ON THIS TOPIC
Podcast
CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP
July 2, 2025
 · 
1 min read
 · 
Heather McKenzie
A contemporary artistic collage depicting a hand holding pills, passing them to another hand. The concept of medication and treatment.
Collaboration
Argenx Makes $1.5B+ Play for UNP’s Macrocyclic Peptides Aimed at ‘Undruggable’ Targets
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage, female palms in the orange circle, a bag of money. Concept of business and finance.
Mergers & acquisitions
AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies
June 30, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Illustration showing businessman bringing personal items in box stock
Layoffs
BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900
June 30, 2025
 · 
1 min read
 · 
Angela Gabriel